Cutler Group LP P Lx Pharma Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
BUY
$1.9 - $4.18 $1,520 - $3,344
800 Added 7.53%
11,424 $27,000
Q1 2022

Apr 14, 2022
SELL
$3.54 - $8.3 $14,160 - $33,200
-4,000 Reduced 27.35%
10,624 $42,000
Q4 2021

Jan 18, 2022
BUY
$7.69 - $19.66 $15,318 - $39,162
1,992 Added 15.77%
14,624 $117,000
Q3 2021

Oct 26, 2021
BUY
$12.22 - $21.28 $154,363 - $268,808
12,632 New
12,632 $243,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email